Saba Capital Takes Activist Stake in BlackRock Science & Tech Term Trust

TL;DR

**Activist investor Saba Capital just revealed a stake in BlackRock Science & Tech Term Trust, brace for potential changes!**

AI Summary

Saba Capital Management, L.P., led by Boaz R. Weinstein, filed an SC 13D on February 5, 2024, disclosing that they became a significant shareholder in BlackRock Science & Technology Term Trust (BSTZ) as of February 1, 2024. This filing indicates Saba Capital's intent to potentially influence the management or policies of BSTZ, which could lead to changes in how the trust operates or distributes value to shareholders. This matters to investors because Saba Capital is known for activist investing in closed-end funds, often pushing for actions like tender offers or conversions to open-end funds, which can impact share price and liquidity.

Why It Matters

Saba Capital's involvement often signals potential activist campaigns in closed-end funds, which could lead to significant changes in the fund's structure or shareholder returns, impacting current and prospective investors.

Risk Assessment

Risk Level: medium — Activist investor involvement can create volatility and uncertainty, but also potential for positive shareholder outcomes.

Analyst Insight

A smart investor would monitor future filings and news regarding BlackRock Science & Technology Term Trust for any announcements of Saba Capital's specific intentions, as activist involvement can lead to significant changes in fund structure or shareholder value. Consider the potential for both upside from activist pressure and downside from uncertainty.

Key Players & Entities

• Saba Capital Management, L.P. (company) — the filer and activist investor
• BlackRock Science & Technology Term Trust (company) — the subject company in which Saba Capital acquired a stake
• Boaz R. Weinstein (person) — group member of Saba Capital Management
• Michael D'Angelo (person) — contact person for Saba Capital Management, L.P.
• February 1, 2024 (date) — date of event requiring the filing
• February 5, 2024 (date) — filing date of the SC 13D
• $0.001 (dollar_amount) — par value of Common Shares of BlackRock Science & Technology Term Trust

Forward-Looking Statements

• Saba Capital Management, L.P. will likely engage in discussions with BlackRock Science & Technology Term Trust's management regarding strategic alternatives. (BlackRock Science & Technology Term Trust) — high confidence, target: Within 6-12 months
• There could be increased volatility in the share price of BlackRock Science & Technology Term Trust as the market reacts to potential activist actions. (BlackRock Science & Technology Term Trust) — medium confidence, target: Within 3 months

FAQ

Key Financial Figures

• $0.001 — rust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securiti
• $65,392,286 — ported herein. A total of approximately $65,392,286 was paid to acquire the Common Shares r

Filing Documents

• formsc13d.htm (SC 13D) — 93KB
• exhibit1.htm (EX-1) — 5KB
• 0001062993-24-001904.txt ( ) — 99KB

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: February 5, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 09260K101 SCHEDULE 13D Page 10 of 10 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital during the past sixty days. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 12/6/2023 Buy 94,731 16.69 12/7/2023 Buy 10,227 16.60 12/7/2023 Buy 62,712 16.64 12/8/2023 Buy 65,187 16.68 12/11/2023 Buy 111,199 16.75 12/12/2023 Buy 80,367 16.85 12/13/2023 Buy 52,247 16.84 12/13/2023 Buy 87,800 17.03 12/14/2023 Buy 25,706 17.16 12/14/2023 Buy 120,960 17.19 12/15/2023 Buy 16,293 17.09 1/2/2024 Buy 23,588 16.52 1/3/2024 Buy 22,512 16.25 1/4/2024 Buy 127,280 16.45 1/9/2024 Buy 20,254 16.95 2/1/2024 Buy 139,448 17.30 2/2/2024 Buy 53,769 17.44

View Full Filing

View this SC 13D filing on SEC EDGAR